CJC Open is a leading open access journal published by Elsevier, focused on advancing the fields of Cardiology and Cardiovascular Medicine. Since its inception in 2019, the journal has committed to disseminating high-quality research and groundbreaking advancements in cardiovascular health. With its ISSN 2589-790X and an impressive Q2 ranking in its field, CJC Open aims to foster collaboration and communication among researchers, healthcare professionals, and students by providing a platform for innovative studies, reviews, and insights. The journal is indexed in Scopus, currently ranking at #191 out of 387 in its category, underscoring its relevance and impact in the academic community. As an open access journal, CJC Open ensures that research findings are widely available, promoting greater visibility and readership. Scientists and practitioners alike are encouraged to submit their work, further enriching the discourse in cardiovascular research. With a focus on quality and accessibility, CJC Open is poised to make significant contributions to the field through 2024 and beyond.

Canadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.

Heart Failure Clinics, published by Elsevier Science Inc, stands at the forefront of research and clinical practice in the rapidly evolving field of cardiology and cardiovascular medicine. With an ISSN of 1551-7136, this prestigious journal has established a reputation for high-quality peer-reviewed articles, offering critical insights into heart failure management, innovative therapies, and health care strategies. Ranked in the Q2 quartile for cardiology and cardiovascular medicine and recognized in the Q1 quartile for miscellaneous medicine as of 2023, it reflects a significant impact on both clinical and academic communities, holding a commendable position in the 73rd percentile of its category according to Scopus rankings. Since its inception in 2005, this journal has continuously been a vital resource for researchers, healthcare professionals, and students aiming to enhance their understanding of heart failure. Although it does not offer full open access options, the depth and relevance of its content make it indispensable for anyone engaged in heart health research and practice. Located in the heart of New York, at 230 Park Ave, STE 800, it aims to foster knowledge exchange and promote advancements in cardiovascular care until its converged years in 2024.

Open Cardiovascular Medicine Journal is a notable scholarly platform published by Bentham Science Publishers Ltd, dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. With an E-ISSN of 1874-1924, this open-access journal has been a beacon for researchers and clinicians alike since its inception in 2009. Acting as a conduit for the latest research findings, the journal fosters interdisciplinary collaboration and innovation, contributing to the overall progress in cardiovascular health. Although currently ranked in the 26th percentile among cardiology journals, it emphasizes high-quality, peer-reviewed articles that uphold the rigorous standards of academic integrity. The journal also benefits from a robust editorial team and an array of publication options, ensuring accessibility and visibility of crucial cardiovascular research. As it continues its journey through 2023 and beyond, Open Cardiovascular Medicine Journal remains essential for anyone invested in the challenges and advancements within the cardiovascular domain.

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

Open Heart is a prestigious, peer-reviewed open access journal published by BMJ Publishing Group, focusing on the dynamic field of Cardiology and Cardiovascular Medicine. Launched in 2013, the journal has rapidly ascended to prominence, achieving a Q1 quartile ranking in its category as of 2023, reflecting its high-quality scholarly contributions. With an active publishing history from 2014 through 2024, Open Heart offers an expansive platform for researchers, clinicians, and students to disseminate and access groundbreaking research findings, reviews, and case studies that address critical issues in cardiovascular health. The journal is indexed in Scopus, ranking 133rd out of 387 in the Medicine - Cardiology and Cardiovascular Medicine category, placing it within the 65th percentile of its peers. Based in the United Kingdom, it promotes global research and collaboration in the cardiovascular domain, ensuring open access to vital knowledge for all stakeholders in the medical community. For access options and more information, visit the Open Heart website.

WIENER KLINISCHE WOCHENSCHRIFT, published by SPRINGER WIEN, is a prestigious medical journal with a rich history dating back to 1946. With an ISSN of 0043-5325 and E-ISSN 1613-7671, it serves as a vital resource for researchers, healthcare professionals, and students engaged in the field of general medicine. The journal holds a commendable Q2 category ranking in Medicine (miscellaneous) and is positioned in the top 18% of its field according to Scopus, ranked #110 out of 636. Although it is not an open-access journal, it offers an essential platform for the dissemination of high-quality research, case studies, and clinical insights from Austria and beyond. The objectives of the journal include advancing medical knowledge, fostering collaborative research, and providing practitioners with the latest findings that inform clinical practice. This makes it an invaluable asset for anyone looking to stay at the forefront of medical research and development.

The Egyptian Heart Journal, published by Springer, is a premier open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. As of 2023, it holds a Q3 classification within the category, showcasing its growing influence within the research community, and ranks 241 out of 387 in Scopus, reflecting a 37th percentile position. With an E-ISSN of 2090-911X, this journal has been open access since 2011, making it easily accessible to researchers, practitioners, and students alike. The journal aims to disseminate high-quality research articles, reviews, and case studies that contribute to the understanding and treatment of cardiovascular diseases. With its focus on innovative and practical solutions in cardiology, the Egyptian Heart Journal plays a critical role in shaping current and future cardiovascular research. Its global outreach and commitment to open access ensure that vital information is available to a wide audience, enhancing both scholarly discourse and clinical practice in the evolving landscape of cardiovascular medicine.

Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.